Evidence map›Paper›PMID 31187844›Full record

ReviewNatural product reports2019

Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.

Lindsay K Caesar, Nadja B Cech

Abstract readReview
In one paragraph

Review in Natural product reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 386 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
386citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

386 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Organ-Specific Phenolic Specialization and Antioxidant Responses inInternational journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Holdfast-Derived Lipid Extract from the Patagonian MacroalgaPharmaceuticals (Basel, Switzerland) · 2026
    Article
  10. Evaluation of Antimicrobial Activity, Toxicity, and Stability ofJournal of microbiology and biotechnology · 2026
    Article
  11. Review
  12. Aqueous Extract ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  13. A Combination ofNutrients · 2026
    Article
  14. Phytochemical Characterization and Effects ofMolecules (Basel, Switzerland) · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Phytochemical Characterization and Toxicity Activity ofMolecules (Basel, Switzerland) · 2026
    Article
  20. Biological Activity ofInternational journal of molecular sciences · 2026
    Article

326 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lindsay K CaesarDepartment of Chemistry & Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina, USA. nadja_cech@uncg.edu.
Nadja B Cech

Funding

Predoctoral Training: Innovative Technologies for Natural Products and Integrative Medicine ResearchT32AT008938 · NCCIH · UNIVERSITY OF NORTH CAROLINA GREENSBORO · PI Nadja B Cech, Jonathan Rodi Chekan · 2016 to 2026
$1.6M
Comparative Bioactivity Modeling and Bioinformatics to Study Combination Effects in Complex Natural Product MixturesR15AT010191 · NCCIH · UNIVERSITY OF NORTH CAROLINA GREENSBORO · PI CECH, NADJA B · 2019 to 2019
$431k
NCCIH NIH HHS R15 AT010191NCCIH NIH HHS T32 AT008938
6 · The paper itself

Abstract

Covering: 2000 to 2019 According to a 2012 survey from the Centers for Disease Control and Prevention, approximately 18% of the U.S. population uses natural products (including plant-based or botanical preparations) for treatment or prevention of disease. The use of plant-based medicines is even more prevalent in developing countries, where for many they constitute the primary health care modality. Proponents of the medicinal use of natural product mixtures often claim that they are more effective than purified compounds due to beneficial "synergistic" interactions. A less-discussed phenomenon, antagonism, in which effects of active constituents are masked by other compounds in a complex mixture, also occurs in natural product mixtures. Synergy and antagonism are notoriously difficult to study in a rigorous fashion, particularly given that natural products chemistry research methodology is typically devoted to reducing complexity and identifying single active constituents for drug development. This report represents a critical review with commentary about the current state of the scientific literature as it relates to studying combination effects (including both synergy and antagonism) in natural product extracts. We provide particular emphasis on analytical and Big Data approaches for identifying synergistic or antagonistic combinations and elucidating the mechanisms that underlie their interactions. Specific case studies of botanicals in which synergistic interactions have been documented are also discussed. The topic of synergy is important given that consumer use of botanical natural products and associated safety concerns continue to garner attention by the public and the media. Guidance by the natural products community is needed to provide strategies for effective evaluation of safety and toxicity of botanical mixtures and to drive discovery in botanical natural product research.

Indexed as

Drug AntagonismDrug CombinationsDrug Evaluation, PreclinicalDrug SynergismEchinaceaEndotoxinsHumansMetabolomicsPlant ExtractsPlants, MedicinalDrug CombinationsEndotoxinsPlant Extracts

Identifiers

PMID31187844
PMCPMC6820002

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.